GeoVax Labs (GOVX) Liabilities and Shareholders Equity (2010 - 2026)

GeoVax Labs (GOVX) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $4.6 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity fell 13.23% year-over-year to $4.6 million; the TTM figure through Jun 2026 stood at $23.1 million (down 34.94% YoY), while the FY2025 annual figure was $6.3 million, down 22.24% from the prior year.
• Liabilities and Shareholders Equity fell to $4.6 million in Q2 2026 per GOVX's latest filing, from $6.3 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $38.6 million in Q3 2022 and bottomed at $3.4 million in Q1 2024.
• Historically, Liabilities and Shareholders Equity has averaged $15.0 million across 5 years, with a median of $10.8 million in 2025.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity plunged 87.75% — and 2025, when it jumped 222.6%.
• GeoVax Labs' Liabilities and Shareholders Equity stood at $31.3 million in 2022, then slumped by 70.39% to $9.3 million in 2023, then dropped by 12.14% to $8.2 million in 2024, then fell by 22.24% to $6.3 million in 2025, then slipped by 26.79% to $4.6 million in 2026.
• Business Quant data shows GOVX's Liabilities and Shareholders Equity at $4.6 million in Q2 2026, $6.3 million in Q4 2025, and $6.7 million in Q3 2025.